Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma

British Journal of Cancer

Volumn 105, Issue 10, 2011, Pages 1582-1592

  Colley, H E ^a   Hearnden, V ^a   Jones, A V ^a   Weinreb, P H ^b   Violette, S M ^c   MacNeil, S ^a   Thornhill, M H ^a   Murdoch, C ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b BIOGEN   (United States)

^c Stromedix Inc   (United States)

Author keywords

dysplasia; invasion; oral mucosa; squamous cell carcinoma; tissue engineered

Indexed keywords

ACELLULAR DERMAL MATRIX; ADULT; ARTICLE; BASEMENT MEMBRANE; CANCER CELL CULTURE; CANCER INVASION; CARCINOMA IN SITU; CELL SUSPENSION; CLINICAL FEATURE; CONNECTIVE TISSUE; CONTROLLED STUDY; DISEASE MODEL; DYSPLASIA; EARLY CANCER; EPIDERMIS; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; MALE; MALIGNANT TRANSFORMATION; MOUTH CARCINOMA; MOUTH MUCOSA; ORAL DYSPLASIA; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TISSUE ENGINEERING; TUMOR BIOPSY; TUMOR GROWTH; TUMOR SEEDING; TUMOR SPHEROID;

CARCINOMA, SQUAMOUS CELL; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; TISSUE ENGINEERING;

EID: 80755146084     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.403     Document Type: Article

References (51)

1. Allen-Hoffmann BL, Rheinwald JG (1984) Polycyclic aromatic hydrocarbon mutagenesis of human epidermal keratinocytes in culture. Proc Natl Acad Sci USA 81: 7802-7806 (Pubitemid 15169149)
2. Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371: 1695-1709 (Pubitemid 351671886)
3. Bhargava S, Chapple CR, Bullock AJ, Layton C, MacNeil S (2004) Tissue-engineered buccal mucosa for substitution urethroplasty. BJU Int 93: 807-811 (Pubitemid 38497032)
4. Bhargava S, Patterson JM, Inman RD, MacNeil S, Chapple CR (2008) Tissue-engineered buccal mucosa urethroplasty-clinical outcomes. Eur Urol 53: 1263-1269
5. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR, Brakenhoff RH (2003) A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63: 1727-1730 (Pubitemid 36460827)
6. Bradley G, Odell EW, Raphael S, Ho J, Le LW, Benchimol S, Kamel-Reid S (2010) Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma. Br J Cancer 103: 1432-1442
7. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, Corio R, Lee D, Greenberg B, Koch W, Sidransky D (1996) Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Res 56: 2488-2492 (Pubitemid 26170679)
8. Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D (2000) Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 6: 347-352 (Pubitemid 30111449)
9. Carlsson J, Yuhas JM (1984) Liquid-overlay culture of cellular spheroids. Recent Results Cancer Res 95: 1-23
10. Chang SE, Foster S, Betts D, Marnock WE (1992) DOK, a cell line established from human dysplastic oral mucosa, shows a partially transformed non-malignant phenotype. Int J Cancer 52: 896-902 (Pubitemid 23009506)
11. Cho KH, Ahn HT, Park KC, Chung JH, Kim SW, Sung MW, Kim KH, Chung PH, Eun HC, Youn JI (2000) Reconstruction of human hard-palate mucosal epithelium on de-epidermized dermis. J Dermatol Sci 22: 117-124
12. Chung JH, Cho KH, Lee DY, Kwon OS, Sung MW, Kim KH, Eun HC (1997) Human oral buccal mucosa reconstructed on dermal substrates: a model for oral epithelial differentiation. Arch Dermatol Res 289: 677-685 (Pubitemid 28014198)
13. Costea DE, Kulasekara K, Neppelberg E, Johannessen AC, Vintermyr OK (2006) Species-specific fibroblasts required for triggering invasiveness of partially transformed oral keratinocytes. Am J Pathol 168: 1889-1897 (Pubitemid 43825309)
14. Eves P, Layton C, Hedley S, Dawson RA, Wagner M, Morandini R, Ghanem G, Mac Neil S (2000) Characterization of an in vitro model of human melanoma invasion based on reconstructed human skin. Br J Dermatol 142: 210-222 (Pubitemid 30117688)
15. Fusenig NE, Breitkreutz D, Dzarlieva RT, Boukamp P, Bohnert A, Tilgen W (1983) Growth and differentiation characteristics of transformed keratinocytes from mouse and human skin in vitro and in vivo. J Invest Dermatol 81: 168s-175s (Pubitemid 13030436)
16. Gaballah K, Costea DE, Hills A, Gollin SM, Harrison P, Partridge M (2008) Tissue engineering of oral dysplasia. J Pathol 215: 280-289 (Pubitemid 351956709)
17. Gioanni J, Fischel JL, Lambert JC, Demard F, Mazeau C, Zanghellini E, Ettore F, Formento P, Chauvel P, Lalanne CM (1988) Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol 24: 1445-1455
18. Ha PK, Benoit NE, Yochem R, Sciubba J, Zahurak M, Sidransky D, Pevsner J, Westra WH, Califano J (2003) A transcriptional progression model for head and neck cancer. Clin Cancer Res 9: 3058-3064 (Pubitemid 36993268)
19. Hearnden V, Lomas H, Macneil S, Thornhill M, Murdoch C, Lewis A, Madsen J, Blanazs A, Armes S, Battaglia G (2009) Diffusion studies of nanometer polymersomes across tissue engineered human oral mucosa. Pharm Res 26: 1718-1728
20. Hunter KD, Thurlow JK, Fleming J, Drake PJ, Vass JK, Kalna G, Higham DJ, Herzyk P, Macdonald DG, Parkinson EK, Harrison PR (2006) Divergent routes to oral cancer. Cancer Res 66: 7405-7413 (Pubitemid 44289192)
21. Jefferies S, Foulkes WD (2001) Genetic mechanisms in squamous cell carcinoma of the head and neck. Oral Oncol 37: 115-126 (Pubitemid 32146656)
22. Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6: 392-401
23. Kim S (2009) Animal models of cancer in the head and neck region. Clin Exp Otorhinolaryngol 2: 55-60
24. Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11: 9-22
25. Lewis MP, Lygoe KA, Nystrom ML, Anderson WP, Speight PM, Marshall JF, Thomas GJ (2004) Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer 90: 822-832 (Pubitemid 38406593)
26. Lim KP, Cirillo N, Hassona Y, Wei W, Thurlow JK, Cheong SC, Pitiyage G, Parkinson EK, Prime SS (2011) Fibroblast gene expression profile reflects the stage of tumour progression in oral squamous cell carcinoma. J Pathol 223: 459-469
27. Mao L, El-Naggar AK, Papadimitrakopoulou V, Shin DM, Shin HC, Fan Y, Zhou X, Clayman G, Lee JJ, Lee JS, Hittelman WN, Lippman SM, Hong WK (1998) Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy. J Natl Cancer Inst 90: 1545-1551 (Pubitemid 28535719)
28. Marsh D, Suchak K, Moutasim KA, Vallath S, Hopper C, Jerjes W, Upile T, Kalavrezos N, Violette SM, Weinreb PH, Chester KA, Chana JS, Marshall JF, Hart IR, Hackshaw AK, Piper K, Thomas GJ (2011) Stromal features are predictive of disease mortality in oral cancer patients. J Pathol 223: 470-481
29. McGregor F, Wagner E, Felix D, Soutar D, Parkinson K, Harrison PR (1997) Inappropriate retinoic acid receptor-beta expression in oral dysplasias: correlation with acquisition of the immortal phenotype. Cancer Res 57: 3886-3889 (Pubitemid 27427669)
30. Moharamzadeh K, Brook IM, Van Noort R, Scutt AM, Smith KG, Thornhill MH (2008) Development, optimization and characterization of a full-thickness tissue engineered human oral mucosal model for biological assessment of dental biomaterials. J Mater Sci Mater Med 19: 1793-1801 (Pubitemid 351409327)
31. Moharamzadeh K, Brook IM, Van Noort R, Scutt AM, Thornhill MH (2007) Tissue-engineered oral mucosa: a review of the scientific literature. J Dent Res 86: 115-124
32. Moutasim KA, Jenei V, Sapienza K, Marsh D, Weinreb PH, Violette SM, Lewis MP, Marshall JF, Fortune F, Tilakaratne WM, Hart IR, Thomas GJ (2011) Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis. J Pathol 223: 366-377
33. Mueller MM, Fusenig NE (2004) Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 4: 839-849 (Pubitemid 39472951)
34. Nystrom ML, McCulloch D, Weinreb PH, Violette SM, Speight PM, Marshall JF, Hart IR, Thomas GJ (2006) Cyclooxygenase-2 inhibition suppresses alphavbeta6 integrin-dependent oral squamous carcinoma invasion. Cancer Res 66: 10833-10842 (Pubitemid 44876979)
35. Nystrom ML, Thomas GJ, Stone M, Mackenzie IC, Hart IR, Marshall JF (2005) Development of a quantitative method to analyse tumour cell invasion in organotypic culture. J Pathol 205: 468-475 (Pubitemid 40361335)
36. Prime SS, Rosser TJ, Scully C (1986) Site-specific distribution of epithelial cell-surface carbohydrates in rat oral mucosa. Differentiation 31: 35-41 (Pubitemid 16089669)
37. Ralston DR, Layton C, Dalley AJ, Boyce SG, Freedlander E, Mac Neil S (1999) The requirement for basement membrane antigens in the production of human epidermal/dermal composites in vitro. Br J Dermatol 140: 605-615 (Pubitemid 29191377)
38. Rangan SR (1972) A new human cell line (FaDu) from a hypopharyngeal carcinoma. Cancer 29: 117-121
39. Reibel J (2003) Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 14: 47-62
40. Rhee JC, Khuri FR, Shin DM (2004) Advances in chemoprevention of head and neck cancer. Oncologist 9: 302-311 (Pubitemid 38756878)
41. Rudin CM, Cohen EE, Papadimitrakopoulou VA, Silverman Jr S, Recant W, El-Naggar AK, Stenson K, Lippman SM, Hong WK, Vokes EE (2003) An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalig-nant oral dysplasia. J Clin Oncol 21: 4546-4552 (Pubitemid 46594025)
42. Saintigny G, Bonnard M, Damour O, Collombel C (1993) Reconstruction of epidermis on a chitosan cross-linked collagen-GAG lattice: effect of fibroblasts. Acta Derm Venereol 73: 175-180 (Pubitemid 23214188)
43. Thomas GJ, Jones J, Speight PM (1997) Integrins and oral cancer. Oral Oncol 33: 381-388 (Pubitemid 28126034)
44. Thomas GJ, Lewis MP, Hart IR, Marshall JF, Speight PM (2001a) AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer 92: 641-650 (Pubitemid 32385704)
45. Thomas GJ, Lewis MP, Whawell SA, Russell A, Sheppard D, Hart IR, Speight PM, Marshall JF (2001b) Expression of the alphavbeta6 integrin promotes migration and invasion in squamous carcinoma cells. J Invest Dermatol 117: 67-73 (Pubitemid 32652441)
46. Thomas GJ, Nystrom ML, Marshall JF (2006) Alphavbeta6 integrin in wound healing and cancer of the oral cavity. J Oral Pathol Med 35: 1-10
47. Torres-Rendon A, Stewart R, Craig GT, Wells M, Speight PM (2009) DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression. Oral Oncology 45: 468-473
48. Vigneswaran N, Beckers S, Waigel S, Mensah J, Wu J, Mo J, Fleisher KE, Bouquot J, Sacks PG, Zacharias W (2006) Increased EMMPRIN (CD 147) expression during oral carcinogenesis. Exp Mol Pathol 80: 147-159
49. Weinreb PH, Simon KJ, Rayhorn P, Yang WJ, Leone DR, Dolinski BM, Pearse BR, Yokota Y, Kawakatsu H, Atakilit A, Sheppard D, Violette SM (2004) Function-blocking integrin alphavbeta6 monoclonal antibodies: distinct ligand-mimetic and nonligand-mimetic classes. J Biol Chem 279: 17875-17887 (Pubitemid 38560556)
50. Wolf K, Alexander S, Schacht V, Coussens LM, von Andrian UH, van Rheenen J, Deryugina E, Friedl P (2009) Collagen-based cell migration models in vitro and in vivo. Semin Cell Dev Biol 20: 931-941
51. Yadev NP, Murdoch C, Saville SP, Thornhill MH (2011) Evaluation of tissue engineered models of the oral mucosa to investigate oral candidiasis. Microb Pathog 50: 278-285